Actinium Pharmaceuticals 뉴스 - ATNM

기업명	주식 심볼	시장	주식 타입
Actinium Pharmaceuticals Inc	ATNM	AMEX	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	0.24	3.66%	6.80	07:56:02

개장가	저가	고가	종가	전일 종가
6.58	6.485	6.92	6.87	6.56

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
18/04/2024	21:00	PRNUS	Actinium Highlights Ability of Iomab-B to Overcome High-Risk..
01/04/2024	21:00	PRNUS	Actinium Announces Iomab-B Phase 3 SIERRA Trial Results..
26/03/2024	20:18	PRNUS	Actinium Announces Clinical Trial to Study Iomab-ACT..
11/03/2024	20:30	PRNUS	Actinium Pharmaceuticals Launches Actinium-225 Focused..
26/02/2024	21:30	PRNUS	Actinium Announces Iomab-B Markedly Increases Long Term..
23/02/2024	21:30	PRNUS	Actinium Highlights Improved Survival with Iomab-B in TP53..
10/02/2024	06:30	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
06/02/2024	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
03/02/2024	07:03	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
02/01/2024	21:30	PRNUS	Actinium Announces Acceptance of Five Abstracts for..
30/12/2023	07:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/12/2023	07:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/12/2023	07:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/12/2023	07:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/12/2023	07:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/12/2023	22:15	PRNUS	Actinium Announces Iomab-B Produces High Response Rates and..
11/12/2023	21:45	PRNUS	Actinium's Four Presentations at ASH Highlight the Positive..
08/12/2023	22:00	PRNUS	Actinium to Highlight Broad Potential of Targeted..
02/12/2023	07:00	EDGAR2	Form 8-K - Current report
10/11/2023	07:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
06/11/2023	21:30	PRNUS	Actinium Presents Preclinical Data at SITC Demonstrating..
03/11/2023	05:15	PRNUS	Actinium Pharmaceuticals to Attend Bio-Europe Munich 2023
02/11/2023	22:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/2023	22:05	PRNUS	Actinium Announces Oral Presentation at ASH Annual Meeting..
04/10/2023	20:30	PRNUS	Actinium Announces NIH Grant Extension to Advance Clinical..
27/09/2023	22:05	PRNUS	Actinium Pharma Highlights Abstract Accepted for Poster..
07/09/2023	21:40	PRNUS	Actinium Pharma Presents Survival Data from Extended..
31/08/2023	20:00	PRNUS	Actinium Pharma Highlights Three Abstracts Accepted for..
21/08/2023	20:00	PRNUS	Actinium Pharma Highlights Abstracts Accepted for Oral and..
15/08/2023	06:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	22:00	EDGAR2	Form S-3 - Registration statement under Securities Act of..
24/07/2023	20:00	PRNUS	Actinium Pharma to Present at the 2nd Annual Targeted..
26/06/2023	20:00	PRNUS	SNMMI 2023 Annual Meeting Abstract of the Year Awarded to..
23/06/2023	21:00	PRNUS	Actinium Pharma Highlights Six Abstracts Accepted for Oral..
16/06/2023	20:00	PRNUS	Actinium Pharma to Present at the Maxim Healthcare Virtual..
14/06/2023	20:00	PRNUS	Actinium Pharma to Present at the TD Cowen..
12/06/2023	20:00	PRNUS	Actinium Announces Positive Pivotal Phase 3 SIERRA Trial..
07/06/2023	20:00	PRNUS	Actinium Pharma Set to Join Russell 2000® and Russell 3000®..
22/05/2023	20:00	PRNUS	Actinium Pharma Announces Six Abstracts Accepted for Oral..
12/05/2023	00:18	PRNUS	Actinium Pharma Announces Iomab-B SIERRA Trial Results..
10/05/2023	20:00	PRNUS	Actinium Pharma to Present at Guggenheim Healthcare Talks..
28/04/2023	21:00	PRNUS	Actinium Highlights Successful Administration of Targeted..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

ATNM Actinium Pharmaceuticals Inc

최근 뉴스

ATNM 과거 데이터 - 1일

ATNM 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Actinium Pharmaceuticals Inc (ATNM) 뉴스

ATNM Actinium Pharmaceuticals Inc

최근 뉴스

ATNM 과거 데이터 - 1일

ATNM 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기